CADASIL syndrome means Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. It is a rare, inherited disease of the small blood vessels in the brain. It causes damage to these tiny arteries, which can lead to small strokes, changes in the white matter of the brain, and later problems with thinking (dementia) and mood. Wikipedia+1
CADASIL syndrome (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) is a rare, inherited disease that damages very small blood vessels in the brain. It is caused by a change (mutation) in the NOTCH3 gene. This damage leads to migraines with aura, small strokes, mood problems, and slow thinking and memory over many years. There is no proven cure or disease-modifying medicine today. Treatment focuses on reducing stroke risk, treating symptoms, and keeping daily life as independent and comfortable as possible.NCBI+1
In CADASIL, the main problem is a change (mutation) in a gene called NOTCH3 on chromosome 19. This gene is important for keeping the smooth muscle cells in blood vessel walls healthy. When NOTCH3 is faulty, these cells get damaged, and abnormal material builds up around them. This makes the brain blood vessels thick and stiff, so blood cannot flow properly, and areas of the brain do not get enough oxygen. Wikipedia+1
CADASIL is passed on in an autosomal dominant way. This means if one parent has the faulty NOTCH3 gene, each child has a 50% chance of inheriting it. It does not come from lifestyle, food, or infection. Symptoms usually start in early or middle adult life with migraine headaches, small strokes, mood problems, and slow loss of memory and thinking skills. NCBI+2PubMed+2
Other names
CADASIL has several medical “other names.” These are different ways of saying the same disease: cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, familial vascular leukoencephalopathy, and hereditary multi-infarct dementia. All of these names describe a family-based brain blood vessel problem that causes many small strokes and white-matter damage leading to dementia. MedlinePlus+1
Doctors and researchers sometimes talk about types or patterns of CADASIL based on how it shows in the body and brain, not as strict official subtypes. One way is to describe it as a hereditary cerebral small vessel disease or genetic microvasculopathy, which means a small artery disease driven by a single gene change. PMC+1
Clinically, doctors may think of “types” by main presentation pattern, for example:
-
Stroke-dominant type – repeated small strokes are the main early problem.
-
Migraine-dominant type – migraine with aura is the first big feature.
-
Psychiatric-dominant type – mood changes, depression, or bipolar-like symptoms are strong.
-
Cognitive-dominant type – memory and thinking problems appear early and clearly.
These are just helpful descriptions; they all represent the same underlying NOTCH3-related disease. PubMed+2bhm.scholasticahq.com+2
Causes of CADASIL syndrome
Remember: the true root cause is a NOTCH3 gene mutation. All other “causes” below are things that explain or influence how the disease appears or worsens, not completely separate causes of a different illness. Wikipedia+1
-
NOTCH3 gene mutation
The direct cause of CADASIL is a harmful change in the NOTCH3 gene. This change makes abnormal NOTCH3 protein that collects in the walls of small arteries in the brain and other organs. This build-up damages the vessel wall and leads to poor blood flow and small strokes. Wikipedia+2ScienceDirect+2 -
Autosomal dominant inheritance
Because the gene is autosomal dominant, a person usually develops CADASIL if they inherit one faulty copy from either mother or father. Having a strong family history of early strokes, migraines with aura, or early dementia is therefore a major causal factor. NCBI+2MedlinePlus+2 -
Specific mutations in NOTCH3 exons
Many CADASIL cases have mutations in certain parts of the NOTCH3 gene called exons 2–24, often affecting cysteine residues. These specific changes alter the shape of the NOTCH3 protein, so it can no longer work properly in blood vessel smooth muscle cells. ScienceDirect+1 -
Abnormal vascular smooth muscle cells
In CADASIL, the smooth muscle cells in small arteries become thick, swollen, and then slowly die. This process leads to narrowing of the vessel and reduced blood supply, which then “causes” the small strokes and white-matter injury over time. Wikipedia+1 -
Granular osmiophilic material (GOM) deposits
Under the microscope, tiny dark granules called granular osmiophilic material build up around smooth muscle cells in small arteries. These deposits are a hallmark of CADASIL and show that the cell environment is abnormal and toxic, which further damages the vessel wall. ScienceDirect+2AHA Journals+2 -
Non-atherosclerotic small vessel disease
CADASIL is a non-atherosclerotic disease, meaning it does not come from cholesterol plaques like typical stroke from large arteries. Instead, the cause is a genetic injury to small vessels, which explains why strokes can occur even without traditional risk factors. PMC+2thejcn.com+2 -
Leukoencephalopathy (white-matter damage)
Because many small vessels are affected, the white matter that depends on them becomes damaged. This “leukoencephalopathy” is both a result and a driving factor for worsening symptoms, such as slow thinking and gait problems. Wikipedia+2Radiopaedia+2 -
Recurrent small subcortical strokes
Repeated small strokes in deep brain areas weaken brain networks over time. Each small infarct may cause only mild symptoms, but many together cause progressive disability and dementia. This repeating injury pattern is therefore a key causal pathway in CADASIL. Wikipedia+2bhm.scholasticahq.com+2 -
Migraine with aura and cortical spreading depression
Many CADASIL patients have migraine with aura. Migraine is linked with “spreading waves” of electrical and blood flow changes in the brain, called cortical spreading depression. Over time, these attacks may add extra stress to already fragile small vessels, contributing to further damage. PMC+2JAMA Network+2 -
Age-related progression
Symptoms usually appear in adulthood and worsen with age. The longer the abnormal NOTCH3 protein is present, the more damage it can cause to small vessels and white matter, so age itself acts as a progression factor. Wikipedia+2NCBI+2 -
Hypertension (high blood pressure)
High blood pressure is not the root cause, but in people with CADASIL it increases stress on already weak small arteries. This can speed up vessel damage and make strokes more likely. NCBI+1 -
Smoking
Smoking damages blood vessels and changes blood flow. In CADASIL patients, smoking has been linked with earlier onset and more severe disease, because it adds extra harm to the vessel wall. NCBI+2bhm.scholasticahq.com+2 -
High cholesterol and other vascular risks
High cholesterol and similar risk factors are not the main cause, but they further injure the vascular system. In someone with CADASIL, this can increase the burden of small strokes and brain injury. NCBI+1 -
Co-existing small vessel diseases
Some people may have other conditions that also affect small brain vessels, such as diabetes-related microangiopathy or other genetic small vessel diseases. When these coexist with CADASIL, they can add to the overall vessel damage load. NCBI+2PMC+2 -
Female hormonal factors (possible modifiers)
Some studies suggest that migraine and stroke risk may be influenced by hormonal states, such as pregnancy or use of estrogen-containing contraceptives, in women with CADASIL, although the gene defect remains the main cause. PMC+1 -
Low “brain reserve” or pre-existing brain injury
If a person already has brain injury from trauma or another disease, the effect of CADASIL-related strokes and leukoencephalopathy may be stronger, causing earlier symptoms and disability. This makes previous brain injury a modifying factor. AHA Journals+1 -
Psychiatric stress and mood disorders
Mood disorders such as depression are partly caused by brain changes in CADASIL, but long-term psychological stress can also worsen sleep, blood pressure, and self-care, indirectly making the disease worse. PubMed+1 -
Poor control of general health
Not taking regular medicines for blood pressure, cholesterol, or other health problems can give additional damage to the already fragile small vessels in CADASIL. Good general health care does not cure CADASIL but helps slow secondary injury. NCBI+1 -
Late or missed diagnosis
If the disease is not recognized early, people may continue harmful habits (like smoking) or miss chances to control other risk factors. Late diagnosis therefore indirectly “causes” worse outcomes by preventing early preventive care. BCBSM+2Cureus+2 -
Lack of family screening
If family members at risk are not tested when appropriate, they may develop strokes or dementia before the condition is known. This lack of family screening does not cause the gene change, but it causes delayed recognition and more damage over time. AAPC+2thejcn.com+2
Symptoms of CADASIL syndrome
-
Migraine headaches with aura
Many people with CADASIL have migraine attacks, often with aura (visual flashes, zig-zag lines, or numbness before the headache). These often start in young or middle adult life and can be one of the earliest signs of the disease. PMC+2American Brain Foundation+2 -
Transient ischemic attacks (TIAs)
TIAs are short episodes when a part of the brain does not get enough blood. The person may have sudden weakness, numbness, or speech problems that last minutes to hours and then fully improve. In CADASIL, these TIAs are common and often happen before larger strokes. Wikipedia+2AHA Journals+2 -
Ischemic strokes
As the disease progresses, full strokes can occur. These are usually small, deep strokes (lacunar strokes) in the white matter or deep nuclei of the brain. They may cause weakness on one side, speech difficulty, or coordination problems. Repeated strokes are a key cause of later disability and dementia. Wikipedia+2Radiopaedia+2 -
Cognitive decline and dementia
Over many years, damage to white matter and repeated strokes cause slow loss of thinking skills. People may have problems with planning, attention, memory, and speed of thinking. This pattern is called subcortical vascular dementia and is a major late feature of CADASIL. ScienceDirect+3Wikipedia+3J Neurosciences Rural Pract+3 -
Slow mental processing
Even before full dementia, many patients notice that it takes longer to think, react, or find words. Tasks such as planning a trip, doing complex work, or handling finances may become more difficult. This slow processing often appears before strong memory loss. PubMed+1 -
Mood disturbances and depression
Depression, apathy (lack of drive), and other mood changes are common in CADASIL. These can be caused both by the brain changes and by emotional reactions to chronic illness and disability. Sometimes mood change is one of the main early signs. American Brain Foundation+2PubMed+2 -
Bipolar-like or psychiatric symptoms
Some people develop more severe mood swings, anxiety, or even psychosis-like symptoms. In a few cases, CADASIL has been mistaken for a primary psychiatric disease before the vascular cause was found, especially when strokes are silent. American Brain Foundation+2PubMed+2 -
Gait disturbance and balance problems
Damage in the subcortical areas and white matter can affect the pathways that control walking and balance. People may have short steps, feel unsteady, or fall more often. Over time, they may need a cane, walker, or wheelchair. Wikipedia+2Radiopaedia+2 -
Urinary urgency or incontinence
As the disease progresses, some people develop problems with bladder control, including urgent need to pass urine or accidental leakage. This is often seen together with gait change and dementia, consistent with a subcortical brain syndrome. Wikipedia+1 -
Confusion or acute encephalopathy
A few patients have sudden episodes of confusion, drowsiness, or reduced awareness called acute encephalopathy. These episodes may follow migraine, infection, or metabolic stress and can be frightening for patients and families. American Brain Foundation+2NCBI+2 -
Visual aura and visual symptoms
Besides migraine aura, CADASIL can cause other visual signs, such as shimmering lights, blind spots, double vision, or visual instability (oscillopsia). These may appear during migraine or as part of transient ischemic episodes. PMC+2EyeWiki+2 -
Speech and language problems
During TIAs or strokes, a person may suddenly have trouble speaking or understanding speech. Even between attacks, some people have slower or less precise language because of underlying white-matter damage. Wikipedia+2Radiopaedia+2 -
Weakness or numbness in limbs
One-sided weakness or numbness, especially in the face, arm, or leg, is common during strokes. Sometimes slight weakness or clumsiness stays even after the main event has passed, adding up over time as more strokes occur. Wikipedia+2bhm.scholasticahq.com+2 -
Headache without aura or chronic headache
Not all headaches in CADASIL are migraine with aura. Some patients have frequent tension-type or non-aura headaches. Because the brain and vessels are abnormal, headache patterns may change over the years. PMC+1 -
Behavior and personality changes
Families may notice that the person becomes more apathetic, less interested in hobbies, more irritable, or less able to control emotions. These changes are often linked to damage in frontal-subcortical circuits in the brain. PubMed+2ScienceDirect+2
Diagnostic tests for CADASIL syndrome
Diagnosis of CADASIL uses clinical features, family history, brain MRI, and gene or skin tests. Below are 20 tests grouped as you requested. Not every patient needs all tests. Doctors choose based on symptoms and local availability. BCBSM+3NCBI+3PMC+3
Physical examination tests
-
General neurological examination
The doctor checks strength, reflexes, sensation, coordination, walking, and speech. In CADASIL, they may find signs of previous small strokes, such as brisk reflexes, weakness, or trouble with coordination and balance. This exam helps show that a small vessel brain disease is likely. NCBI+1 -
Cognitive and mental status examination
The doctor talks with the patient and may do simple in-office tests to check memory, attention, language, and problem solving. Even before full dementia, CADASIL patients may show slow thinking and executive dysfunction, which supports the diagnosis of a subcortical vascular process. PubMed+1 -
Gait and balance examination
Watching how a person walks, turns, and stands helps show how much the disease is affecting movement pathways. Short steps, wide-based gait, and trouble turning are common in advanced CADASIL and relate to the amount of white-matter damage seen on scans. Wikipedia+2Radiopaedia+2 -
Cardiovascular examination
The doctor checks blood pressure, heart sounds, and pulses. Although CADASIL is not mainly a heart disease, high blood pressure and other vascular risk factors can worsen outcomes, so this exam is important for full stroke risk assessment and management. NCBI+1
Manual and bedside tests
-
Mini-Mental State Examination (MMSE)
The MMSE is a brief paper-and-pencil test that measures orientation, recall, attention, and language. In CADASIL, MMSE scores may slowly drop as dementia develops. It is simple and widely used, but may miss early executive problems, so it is often combined with other tests. PubMed+2thejcn.com+2 -
Montreal Cognitive Assessment (MoCA)
The MoCA is another screening test that better checks executive functions and attention. It can detect early cognitive changes in CADASIL before the MMSE becomes clearly abnormal, making it useful for early monitoring. ScienceDirect+1 -
Depression and mood scales
Tools such as the Patient Health Questionnaire-9 (PHQ-9) or Hamilton Depression Rating Scale may be used to measure depression in CADASIL. Because mood symptoms are common and treatable, these scales help guide treatment and track response over time. PubMed+1 -
Functional and disability scales
Scales like the Modified Rankin Scale or activities of daily living questionnaires help measure how much strokes and cognitive decline affect daily life. In CADASIL, these scores often worsen gradually, reflecting disease progression and helping in clinical follow-up. AHA Journals+2bhm.scholasticahq.com+2
Laboratory and pathological tests
-
Basic blood tests (CBC, electrolytes, glucose, lipids)
Routine blood tests do not diagnose CADASIL but help rule out other causes of strokes and dementia, such as diabetes, severe anemia, infections, or very high cholesterol. Normal results with clear small vessel disease on imaging may raise suspicion for a genetic cause like CADASIL. NCBI+1 -
Coagulation and thrombophilia tests
Tests of blood clotting (like PT, aPTT) or specific clotting factor abnormalities are sometimes done in young stroke patients. In CADASIL, these tests are usually normal, which again pushes the doctor to think about hereditary small vessel causes instead. NCBI+1 -
NOTCH3 genetic testing (diagnostic DNA test)
This is the gold standard for confirming CADASIL. A blood sample is taken, and the NOTCH3 gene is sequenced to look for known pathogenic variants. If a typical NOTCH3 mutation is found, the diagnosis is confirmed and other expensive tests may not be needed. AAPC+2Avalon+2 -
Cascade genetic testing in family members
Once a mutation is found in one person, at-risk relatives can be offered targeted testing for that same mutation. This helps find family members who carry the gene before they show symptoms, allowing early monitoring and counseling. AAPC+2BCBSM+2 -
Skin biopsy with electron microscopy
If genetic testing is not available or is inconclusive, a small skin sample can be taken and examined under an electron microscope. In CADASIL, characteristic granular osmiophilic material (GOM) is seen around small arteries. This finding strongly supports the diagnosis. AHA Journals+3PMC+3ScienceDirect+3 -
Immunostaining for NOTCH3 in skin vessels
Special staining can also be used on skin biopsy samples to show abnormal NOTCH3 protein build-up in the vessel walls. This technique increases the sensitivity of skin biopsy and can help when electron microscopy is not perfect or available. ScienceDirect+2Ovid+2
Electrodiagnostic and neurophysiologic tests
-
Electroencephalogram (EEG)
EEG records the brain’s electrical activity. In CADASIL, it may be ordered if a patient has seizures, acute confusion, or episodic unresponsiveness. The EEG can help rule out epilepsy or show global slowing in severe encephalopathy, though it is not specific for CADASIL. NCBI+1 -
Evoked potentials (visual or somatosensory)
Evoked potentials measure how quickly and strongly the nervous system responds to visual or sensory stimuli. In CADASIL, delays in these responses may reflect white-matter damage and help document the physiological effect of lesions seen on MRI. thejcn.com+1 -
Formal neuropsychological testing (computer- or paper-based)
A detailed series of memory, attention, language, and problem-solving tests can map the pattern of cognitive problems in CADASIL. These tests often show prominent executive dysfunction and slowed thinking, which matches the pattern of subcortical vascular dementia. ScienceDirect+2J Neurosciences Rural Pract+2
Imaging tests
-
Brain MRI (Magnetic Resonance Imaging)
MRI is the most important imaging test for CADASIL. It shows white-matter hyperintensities (bright areas) in characteristic locations such as the anterior temporal lobes and external capsules, as well as old small strokes. These findings, together with family history and symptoms, strongly suggest CADASIL even before genetic confirmation. thejcn.com+3Wikipedia+3Radiopaedia+3 -
CT scan of the brain
A CT scan is faster and more widely available than MRI but less sensitive for white-matter changes. It may show old small strokes or brain atrophy in CADASIL, especially in later stages, and is often used in emergency stroke work-up. However, a normal CT does not rule out the disease. NCBI+2AHA Journals+2 -
MR angiography or CT angiography
These tests image the larger and medium-sized brain arteries. In CADASIL, they are often normal because the main problem is in tiny small vessels. A normal angiogram with clear MRI white-matter disease in a younger person can therefore support the idea of a small vessel disorder like CADASIL instead of large-vessel atherosclerosis. NCBI+2Radiopaedia+2
Non-Pharmacological Treatments
-
Blood pressure control with lifestyle
Keeping blood pressure in a healthy range is one of the most important goals in CADASIL. High blood pressure makes the small brain vessels more fragile and can increase stroke and bleeding risk. Lifestyle steps include reducing salt, avoiding processed foods, maintaining a healthy weight, regular walking, and managing stress. These simple habits support the effect of medicines your doctor may prescribe.NCBI+1 -
Stopping smoking
Smoking directly damages blood vessel walls and makes blood more likely to clot. In CADASIL, where vessels are already diseased, tobacco greatly raises stroke risk. Stopping smoking can slow further damage, reduce heart and lung problems, and improve overall survival. Support programs, counseling, and nicotine replacement can make quitting more successful and safer.NCBI+1 -
Limiting alcohol intake
Heavy alcohol use increases blood pressure, raises the risk of bleeding in the brain, and can worsen mood and sleep. In CADASIL, moderate or no alcohol is usually advised. Small amounts may be acceptable in some people, but binge drinking is dangerous. A doctor can give specific limits based on age, medicines, and liver health. -
Regular aerobic exercise
Gentle, regular exercise such as brisk walking, stationary cycling, or swimming improves blood flow, lowers blood pressure, and supports mood and thinking. In CADASIL, exercise is usually tailored to stroke symptoms and balance problems. A physiotherapist can design a safe program to avoid falls but still provide cardiovascular benefits.AHA Journals -
Physiotherapy (physical therapy)
Physiotherapy focuses on strength, balance, and coordination after strokes or transient ischemic attacks (TIAs). In CADASIL, repeated small strokes can cause weakness or gait problems. The therapist uses exercises, balance training, and walking aids to keep the person mobile and independent for as long as possible. Ongoing therapy may slow functional decline.ScienceDirect -
Occupational therapy
Occupational therapists help the person manage daily activities, such as dressing, bathing, cooking, and using devices. They may suggest home modifications like grab rails, shower chairs, or special kitchen tools. In CADASIL, this can reduce falls, prevent injuries, and let people stay in their homes longer, even as physical or cognitive problems progress. -
Speech and language therapy
After strokes, some people develop slurred speech, difficulty finding words, or trouble swallowing. Speech and language therapists help with exercises for clearer speech, safe swallowing strategies, and alternative ways to communicate. In CADASIL, these therapies can be used repeatedly as new strokes occur. -
Cognitive rehabilitation
Cognitive rehabilitation includes exercises and strategies to help with memory, attention, planning, and problem solving. In CADASIL, thinking and memory often decline slowly over time. Therapists may teach writing notes, using calendars, setting phone reminders, or breaking tasks into small steps. This does not cure the disease but can increase independence.Genomics Education -
Psychological counseling and psychotherapy
Depression, anxiety, irritability, and personality changes are common in CADASIL. Talking therapies such as cognitive-behavioral therapy (CBT) can help the patient and family cope with mood symptoms, stress, and fear about the future. Counseling also supports adjustment to disability, job loss, and changes in family roles.EUCTIN -
Family and genetic counseling
CADASIL is an autosomal dominant condition, so children of an affected person have a 50% chance of inheriting the mutation. Genetic counseling explains the inheritance pattern, testing options, and reproductive choices. It also offers emotional support when family members must decide whether they want to be tested.thejcn.com+1 -
Education about stroke warning signs
Teaching patients and families the sudden signs of stroke—face drooping, arm weakness, speech difficulty, sudden vision or balance problems—helps them seek emergency care quickly. Fast treatment may limit brain damage, even though CADASIL-related strokes can be different from typical large-artery strokes. -
Fall-prevention strategies
Balance problems, weakness, and visual issues can cause falls. Simple measures include removing loose rugs, using good lighting, installing handrails on stairs, and wearing supportive shoes. Physical therapy can add balance exercises. Preventing falls reduces fractures, head injuries, and hospital stays. -
Sleep hygiene and treating sleep disorders
Good sleep supports brain health and mood. People with CADASIL may have insomnia, fragmented sleep, or sleep apnea. Regular sleep times, avoiding caffeine late in the day, and limiting screen time at night can help. If sleep apnea is suspected (loud snoring, pauses in breathing), a sleep study and CPAP treatment may be needed. -
Stress management and relaxation techniques
Chronic stress may raise blood pressure and worsen migraines. Relaxation methods such as deep breathing, mindfulness, gentle yoga, or guided imagery can calm the nervous system. While they do not change the disease itself, they may reduce migraine frequency and improve quality of life.SAGE Journals -
Migraine trigger management
In CADASIL, migraine with aura is very common. People are encouraged to keep a “migraine diary” to identify triggers such as lack of sleep, dehydration, stress, bright lights, or certain foods. Avoiding these triggers can lower the number of migraine attacks and lessen the need for medicines.PMC+1 -
Nutritional counseling for vascular health
A dietitian can design a meal plan that is low in salt, refined sugar, and unhealthy fats and rich in fruits, vegetables, whole grains, and healthy oils. This supports blood pressure, cholesterol, and weight control. In CADASIL, this helps reduce additional vascular injury in the brain.Stroke Manual -
Social support and caregiver support groups
Living with a progressive brain condition is emotionally heavy for patients and caregivers. Support groups—local or online—provide a safe place to share experiences, learn coping strategies, and reduce feelings of isolation. Strong social support is linked to better mood and slower functional decline in many chronic brain diseases. -
Work and driving assessment
Occupational therapists and doctors may evaluate whether it is safe to continue driving or working. Adjustments such as reduced hours, modified tasks, or stopping driving may be needed. Early planning can avoid accidents and reduce stress. -
Advance care planning
Because CADASIL can cause progressive cognitive decline, it is wise to discuss wishes for future medical care while the person can still decide. This includes preferences about resuscitation, life support, feeding tubes, or where they would like to live later. Written advance directives guide doctors and families. -
Participation in clinical research
There is growing research into gene-based and cell-based therapies, as well as new drugs to protect small vessels or modify NOTCH3 signaling. Taking part in carefully designed clinical trials at experienced centers may give access to experimental options and helps build knowledge for future patients.Springer+1
Drug Treatments
There is no drug that cures CADASIL or is specifically approved by the FDA for CADASIL itself. Medicines are used to control risk factors (such as hypertension and high cholesterol) and to treat symptoms (such as migraine, depression, and seizures).NCBI+1
Doses below are typical adult ranges; exact dose and timing must be set by a physician.
-
Aspirin (low-dose)
Aspirin is an antiplatelet drug (NSAID) used to prevent clots in arteries in people at risk of stroke or heart attack. It works by blocking an enzyme (COX-1) in platelets, reducing their ability to clump together. In some CADASIL patients who have had ischemic stroke or TIA, low-dose aspirin (often 75–100 mg once daily) may be considered, but its benefit is not proven and bleeding risk must be weighed carefully.NCBI+2FDA Access Data+2 -
Clopidogrel
Clopidogrel is another antiplatelet medicine that prevents platelets from clumping by blocking the P2Y12 receptor. It is often given 75 mg once daily to reduce risk of stroke or heart attack in high-risk patients. In CADASIL, it may be used in selected individuals with prior ischemic events, but, again, specific benefit for this disease is uncertain, and there may be concerns about bleeding, especially if there are many microbleeds on MRI.AHA Journals+1 -
Blood pressure-lowering medicines (ACE inhibitors such as perindopril)
ACE inhibitors block an enzyme that makes angiotensin II, a substance that tightens blood vessels. By relaxing vessels, they lower blood pressure and protect the brain and kidneys. A typical dose might be perindopril 4–8 mg once daily. In CADASIL, good blood pressure control is crucial to reduce additional small-vessel damage and stroke risk.NCBI -
Angiotensin receptor blockers (ARBs such as losartan)
ARBs block the angiotensin II receptor on blood vessel walls, leading to relaxation and reduced blood pressure. Common doses might be losartan 50–100 mg daily. They are often used when ACE inhibitors are not tolerated. In CADASIL, they help control hypertension with a similar protective effect on small vessels. -
Calcium-channel blockers (such as amlodipine)
These drugs relax blood vessel muscle by blocking calcium entry into cells. Amlodipine, often 5–10 mg once daily, is a common choice. They reduce blood pressure and may be particularly useful when combined with other agents for resistant hypertension in CADASIL patients. -
Statins (such as atorvastatin)
Statins lower LDL (“bad”) cholesterol and stabilize atherosclerotic plaques. A typical atorvastatin dose is 10–40 mg once daily. While CADASIL is a genetic small-vessel disease rather than large-artery atherosclerosis, statins are used to control traditional vascular risk factors and may reduce overall stroke risk.AHA Journals+1 -
Acetazolamide (migraine prevention)
Acetazolamide is a carbonic anhydrase inhibitor that changes brain fluid chemistry and can stabilize neuronal excitability. It is sometimes used off-label to prevent migraine with aura, including in CADASIL, at doses such as 250–500 mg two or three times daily. Studies suggest it may reduce attack frequency, but evidence is limited and side effects (tingling, kidney stones, fatigue) must be monitored.SAGE Journals+1 -
Sodium valproate (migraine and seizure control)
Valproate is an antiepileptic drug that increases GABA, an inhibitory neurotransmitter. It is used for migraine prevention and epilepsy. Typical doses range from 500–1500 mg/day in divided doses. In CADASIL, it may help with migraine and seizures, but it has important side effects (weight gain, liver toxicity, teratogenicity), so careful monitoring is needed.PMC+1 -
Topiramate (migraine prevention)
Topiramate blocks certain ion channels and modulates neurotransmitters, stabilizing brain activity. Common doses are 50–100 mg daily in divided doses. In CADASIL, it may reduce migraine frequency and intensity. Side effects can include tingling, weight loss, and cognitive slowing, which must be balanced against potential benefits.PMC+1 -
Lamotrigine (migraine with aura and seizures)
Lamotrigine stabilizes neuronal membranes by blocking sodium channels and may reduce cortical spreading depression, which is part of migraine aura. Doses are slowly increased, often up to 100–200 mg/day. In CADASIL, it has been used to manage migraine aura and seizures, but must be titrated carefully to avoid severe skin reactions. -
Triptans (such as sumatriptan – acute migraine treatment)
Triptans activate serotonin (5-HT1B/1D) receptors on blood vessels and nerve endings, reducing inflammation and narrowing dilated cranial vessels. They are taken at the start of a migraine attack, for example sumatriptan 25–100 mg orally. Earlier concern about their safety in CADASIL is being reconsidered; some reviews suggest they can be used with caution under specialist guidance.EUCTIN+2PMC+2 -
Selective serotonin reuptake inhibitors (SSRIs – such as sertraline)
SSRIs increase serotonin levels in the brain and are widely used to treat depression and anxiety. Sertraline doses often range from 50–200 mg once daily. In CADASIL, they can improve mood, reduce irritability, and help patients cope with chronic illness. Doctors monitor for interactions with other medicines and bleeding risk when combined with antiplatelet drugs.EUCTIN -
Other antidepressants (such as mirtazapine)
Mirtazapine acts on serotonin and noradrenaline receptors and can help with depression, anxiety, poor appetite, and insomnia. Typical doses are 15–45 mg at night. In CADASIL, mirtazapine may be useful for combined mood and sleep problems. It can cause weight gain and daytime drowsiness, so benefits and side effects must be reviewed. -
Antiepileptic drugs (such as levetiracetam)
Levetiracetam modulates neurotransmitter release and is used to control focal and generalized seizures. Doses commonly range from 500–3000 mg/day in divided doses. In CADASIL, it is used when seizures occur because of cortical strokes or scarring. It usually has a favorable side-effect profile but can sometimes cause mood changes. -
Proton-pump inhibitors (PPIs – such as omeprazole, when needed)
PPIs reduce stomach acid by blocking the proton pump in stomach cells. Doses like omeprazole 20 mg once daily are common. In CADASIL, they may be prescribed to reduce the risk of stomach bleeding when the patient must take antiplatelet medicines, especially if there is a history of ulcers.FDA Access Data -
Diabetes medicines (such as metformin)
If the patient also has type 2 diabetes, metformin and other antidiabetic drugs improve blood sugar control, which protects small blood vessels in the brain, eyes, and kidneys. Typical metformin doses are 500–2000 mg/day in divided doses. Keeping blood sugar near normal reduces additional small-vessel damage.NCBI+1 -
Lipid-lowering add-on agents (such as ezetimibe)
For people whose cholesterol is still high despite statins, ezetimibe (10 mg once daily) can further reduce LDL by blocking intestinal absorption of cholesterol. This helps optimize vascular risk control, though its direct effect on CADASIL progression is unknown. -
Analgesics (simple pain relievers such as acetaminophen)
Paracetamol (acetaminophen) is often used to treat mild headache or pain without affecting platelets. Typical doses are up to 3–4 g/day in divided doses in adults, depending on local guidance. In CADASIL, it is often preferred over frequent NSAID use to avoid additional bleeding risk, especially when antiplatelets are used. -
Antispasticity medications (such as baclofen or tizanidine)
After repeated strokes, some people develop muscle stiffness or spasticity. Drugs such as baclofen or tizanidine relax muscles by acting on the spinal cord or central nervous system. Doses are individualized and slowly increased. These medicines can improve comfort and mobility but may cause drowsiness or dizziness. -
Emerging experimental drugs (clinical trials)
Researchers are studying agents that may target NOTCH3 signaling, oxidative stress, or small-vessel inflammation. These drugs are not approved for routine use and are only given in clinical trials with close monitoring. Their purpose is to slow or modify disease progression, but benefits and risks are still being evaluated.Springer+2ADS+2
Dietary Molecular Supplements
Evidence for supplements in CADASIL is limited and mostly indirect. They should never replace prescribed medicines or lifestyle measures.
-
Omega-3 fatty acids (fish oil) – May modestly lower triglycerides, reduce inflammation, and support heart and brain health. Typical doses are 1–2 g/day of EPA+DHA, with higher doses only under medical supervision.
-
Vitamin D – Low vitamin D is common and linked to worse bone health and possibly vascular risk. Supplement doses vary (for example, 800–2000 IU/day), based on blood levels.
-
Folate and vitamin B12 – These vitamins help control homocysteine, an amino acid associated with vascular disease when elevated. Supplement doses depend on deficiency status; typical folate doses are 400–1000 mcg/day, B12 500–1000 mcg/day orally or by injection.
-
Coenzyme Q10 – A mitochondrial cofactor that may support cellular energy and act as an antioxidant. Doses often range from 100–300 mg/day. Human evidence in CADASIL is lacking, so it is considered experimental supportive care.
-
Magnesium – Magnesium may help some patients with migraine. Oral magnesium (for example 200–400 mg/day) can support nerve function and vasodilation, but high doses may cause diarrhea or interact with kidney disease.
-
B-complex vitamins – A balanced B-vitamin supplement supports energy metabolism and nerve function. Low doses are usually safe but should not exceed recommended upper limits without medical guidance.
-
Vitamin C and E (antioxidants) – These vitamins help neutralize free radicals. Theoretically they may support small-vessel health, but high-dose antioxidant supplements have not clearly shown stroke benefit and may even be harmful in some situations, so doses should stay within standard ranges.
-
L-arginine or citrulline – Amino acids involved in nitric oxide production, which dilates blood vessels. Evidence in CADASIL is minimal; these supplements should be used only after medical consultation due to possible blood pressure effects.
-
Probiotics – A healthy gut microbiome may support vascular and metabolic health. Probiotic supplements or fermented foods can be part of a balanced plan, though specific CADASIL data do not exist.
-
Multivitamin tailored by a dietitian – Sometimes, a simple, balanced multivitamin is safer and more rational than many single, high-dose supplements. A dietitian and doctor can select a product that covers basic needs without excess.
Regenerative, Immunity-Boosting, and Stem-Cell-Related Approaches
-
Mesenchymal stem cell (MSC) therapy (experimental)
MSC therapy infuses stem cells from bone marrow or fat into the bloodstream to release growth factors and anti-inflammatory signals. In theory, they might protect small vessels and brain tissue. For CADASIL, this is research only, used in trials under strict protocols, with unknown long-term benefits or risks.Springer+1 -
Gene therapy targeting NOTCH3 (experimental)
Future treatments may try to silence or correct the mutant NOTCH3 gene using viral vectors or gene-editing tools. The goal is to prevent the toxic protein from damaging vessel walls. This is still in preclinical or very early clinical research and not available for routine care.Springer+1 -
Cell-based vascular repair strategies
Researchers are exploring ways to use endothelial progenitor cells or other vascular cells to repair damaged small vessels. Such therapies might be delivered through injections or infusions. At present, these strategies remain experimental in laboratories and early-phase clinical studies. -
Neurotrophic factor delivery
Some experimental drugs attempt to deliver proteins that support neuron survival (neurotrophic factors). In theory, these could protect brain cells from ischemic damage. For CADASIL, this area is still theoretical and part of broader stroke research rather than established treatment. -
Immunomodulatory agents (research settings)
Although CADASIL is mainly a genetic and vascular disease, immune pathways may contribute to vessel damage. Trials may test drugs that gently modulate inflammation. These medicines are not standard therapy and must not be used outside controlled studies, due to uncertain risk–benefit balance. -
Lifestyle-based “immune support”
The safest “immunity boosting” strategies are basic: enough sleep, healthy diet, vaccinations (like influenza and pneumococcal vaccines), regular exercise, and stress reduction. These support general immune function and reduce infections, which can trigger strokes or confusion in vulnerable brains.
Surgeries and Procedures
-
Carotid endarterectomy (rare in pure CADASIL)
If a CADASIL patient also has severe narrowing (stenosis) in a large neck artery, surgeons may remove plaque from the artery wall to prevent future strokes. This operation is not for CADASIL itself but for co-existing atherosclerosis. Careful imaging and risk discussion are essential. -
Carotid artery stenting
Instead of open surgery, a stent may be placed inside a narrowed carotid artery through a catheter. Again, this targets separate large-artery disease, not small-vessel CADASIL, and must be considered very carefully because the brain vessels are already fragile. -
Decompressive craniectomy for malignant stroke
In rare cases of very large brain swelling after a major stroke, part of the skull may be temporarily removed to relieve pressure. This life-saving procedure is used in many stroke types. In CADASIL, the decision is complex and depends on age, severity, and the patient’s prior wishes. -
Ventriculoperitoneal (VP) shunt for hydrocephalus
If cerebrospinal fluid builds up and causes pressure in the brain (hydrocephalus), a shunt can be placed to drain fluid to the abdomen. This is uncommon in CADASIL but may be considered if imaging shows treatable pressure. -
Feeding tube placement
When swallowing is very unsafe and repeated aspiration occurs, a percutaneous endoscopic gastrostomy (PEG) tube may provide long-term nutrition. This is sometimes considered in advanced CADASIL after repeated strokes. Decisions should involve the patient (if possible), family, and care team, based on quality-of-life goals.
Prevention Strategies
-
Keep blood pressure in the target range recommended by your doctor.
-
Do not smoke; if you smoke now, seek help to quit.
-
Maintain healthy cholesterol and blood sugar levels.
-
Exercise regularly within safe limits.
-
Eat a heart- and brain-healthy diet (see below).
-
Manage migraines early and avoid known triggers.
-
Take prescribed medicines exactly as directed; do not stop suddenly.
-
Avoid head injuries by reducing fall risks and using seat belts and helmets.
-
Treat depression, anxiety, and sleep problems promptly.
-
Attend regular follow-up appointments and consider clinical trial options when appropriate.NCBI+2NCBI+2
When to See Doctors
You should see a doctor regularly for planned follow-ups, even if you feel well, to review blood pressure, cholesterol, mood, thinking, and any new symptoms. You should seek urgent medical attention (emergency department or ambulance) if you notice sudden weakness or numbness on one side of the body, sudden trouble speaking, sudden vision problems, sudden severe headache, sudden loss of balance, or new confusion. These can be signs of stroke or bleeding.
You should also see your doctor soon (within days) if you notice more frequent migraines, new seizures, a big change in mood or behavior, much worse memory or thinking, repeated falls, swallowing problems, or major weight loss. Early evaluation can prevent complications and adjust treatment.NCBI+1
What to Eat and What to Avoid
-
Eat plenty of colorful vegetables and fruits – They provide vitamins, minerals, and antioxidants that support blood vessels and overall brain health.
-
Choose whole grains – Brown rice, oats, whole-grain bread, and lentils provide fiber that helps control cholesterol and blood sugar.
-
Use healthy fats – Prefer olive oil, canola oil, nuts, seeds, and fatty fish instead of butter and deep-fried foods.
-
Limit salt – Reduce salted snacks, instant noodles, pickles, and very salty sauces to help lower blood pressure.
-
Choose lean proteins – Fish, skinless poultry, beans, and tofu are good options; limit processed meats like sausages and salami.
-
Stay hydrated – Drink enough water through the day unless your doctor gives special fluid limits. Dehydration can trigger migraines and low blood pressure.
-
Limit added sugar – Reduce sweets, sugary drinks, and desserts, especially if you have diabetes or are overweight.
-
Limit alcohol – If allowed by your doctor, keep alcohol low; many people with CADASIL are advised to avoid it.
-
Avoid frequent fast food – Fast foods are often high in salt, unhealthy fats, and calories, which worsen vascular risk factors.
-
Work with a dietitian – A professional can tailor the diet to your culture, preferences, and medical conditions while still protecting your brain and blood vessels.Stroke Manual+1
Frequently Asked Questions
-
Is there a cure for CADASIL syndrome?
No, there is currently no cure or proven disease-modifying medicine for CADASIL. Treatment focuses on controlling vascular risk factors, managing symptoms like migraine and depression, and supporting function through rehabilitation and psychological care.NCBI+2NCBI+2 -
Can CADASIL be prevented in someone who carries the gene?
The gene mutation itself cannot be prevented once inherited, but good control of blood pressure, cholesterol, diabetes, and lifestyle factors may delay or reduce complications. Genetic counseling can discuss options such as prenatal or preimplantation testing for families planning children.thejcn.com+1 -
Do all people with the NOTCH3 mutation get severe disease?
No. The severity and age of onset vary widely even within the same family. Some people develop many strokes and disability in mid-life, while others have milder disease or later symptoms. Researchers are still studying why this happens.thejcn.com -
Are antiplatelet medicines like aspirin always needed?
Not always. In CADASIL, the benefit of antiplatelet therapy for stroke prevention is uncertain, and there is concern about bleeding, especially when there are many microbleeds on MRI. Doctors decide case-by-case, especially after ischemic stroke or TIA.NCBI+2Wiley Online Library+2 -
Can I use triptan medicines for migraine if I have CADASIL?
Recent data suggest that triptans can often be used safely in CADASIL under specialist guidance, although earlier there were concerns. The decision depends on your stroke history, other risk factors, and the neurologist’s judgment.EUCTIN+2PMC+2 -
Are CGRP-blocking migraine drugs safe in CADASIL?
Experts have raised theoretical concerns that blocking CGRP might reduce protective blood vessel dilation. Because CADASIL already affects small vessels, many specialists are cautious and may prefer traditional migraine preventives instead, until more data are available.SAGE Journals -
Will I definitely develop dementia if I have CADASIL?
Many people with CADASIL develop some cognitive decline over time, but the speed and severity differ. Good risk-factor management, active rehabilitation, and treating mood and sleep problems may help maintain function longer, though they do not stop the disease entirely.NCBI+1 -
Can lifestyle changes really make a difference?
Yes. While lifestyle changes cannot remove the gene mutation, they can reduce extra stress on your brain vessels. Not smoking, controlling blood pressure, exercising, and eating a healthy diet can lower the risk of additional strokes and heart disease.NCBI+2AHA Journals+2 -
Is pregnancy safe for someone with CADASIL?
Pregnancy places extra demands on the heart and blood vessels. Some women with CADASIL have uncomplicated pregnancies, while others may be at higher risk of stroke or blood pressure problems. A high-risk obstetrician and neurologist should plan and monitor pregnancy carefully. -
Should my children be tested for CADASIL?
Genetic testing is a personal decision. Some adults want to know their status; others prefer not to. Testing is usually not done in young children unless there is a clear medical benefit. A genetic counselor can explain pros and cons and support the decision.thejcn.com+1 -
Can CADASIL look like multiple sclerosis or other diseases?
Yes. CADASIL can cause white-matter changes on MRI that may resemble multiple sclerosis or other small-vessel diseases. A detailed history, MRI pattern, and genetic testing help distinguish CADASIL from these conditions.thejcn.com+1 -
How often should I have brain MRI scans?
There is no single rule. Some doctors repeat MRI every few years to monitor progression, especially if symptoms change. In other cases, imaging is done only when new problems occur. The schedule is individualized based on age, symptoms, and clinical judgment. -
Does CADASIL affect other organs besides the brain?
CADASIL mainly affects small vessels in the brain, but some studies suggest involvement of other small vessels, such as in the skin and possibly the eyes. Skin biopsy can help confirm the diagnosis by showing characteristic changes.thejcn.com+1 -
Can I still work if I have CADASIL?
Many people continue working for years, especially in early or mild stages. Over time, fatigue, concentration problems, or physical disability may require adapted tasks, reduced hours, or, eventually, stopping work. Occupational therapy and vocational counseling can help plan these changes. -
Where can I find reliable information and support?
Reliable sources include academic neurology centers, national stroke or rare disease organizations, and peer-reviewed medical resources such as GeneReviews and major neurology textbooks or guidelines. Patient support groups and rare-disease charities can also provide community and practical advice.NCBI+1
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 21, 2025.
